Net sales of top 100 pharma cos up by 18.4%, profits rise by 13.2% in FY'12: Pharmabiz study
08:49 EDT 9 Aug 2012 | PharmaBiz
Indian Pharmaceutical industry continues to perform well despite worldwide economic crisis, steep erosion in rupee value and tough competition in the international market.
Original Article: Net sales of top 100 pharma cos up by 18.4%, profits rise by 13.2% in FY'12: Pharmabiz study
More From BioPortfolio on "Net sales of top 100 pharma cos up by 18.4%, profits rise by 13.2% in FY'12: Pharmabiz study"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
